Drug Type Stem cell therapy |
Synonyms Graft versus host disease mesenchymal stem cell therapy(SCM Lifescience), SCM CGH |
Target- |
Action- |
Mechanism Cell replacements |
Therapeutic Areas |
Active Indication- |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingPhase 2 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Chronic graft-versus-host disease | Phase 2 | United States | 28 Sep 2016 | |
Steroid Refractory Graft Versus Host Disease | Phase 2 | United States | 28 Sep 2016 |